Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer
Clinical trial NCT02289547 · UNKNOWN
Trial details
- NCT number
- NCT02289547
- Sponsor
- The Catholic University of Korea
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2018-01-01
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.